Keyword: Turing Pharmaceuticals
The day of judgment is near for Martin Shkreli, who has told a court he is misunderstood and deserves leniency.
Repeated drug price hikes have caught plenty of criticism lately, but the attention isn't dissuading everyone.
Sick of dealing with generic drug shortages and price increases, five large U.S. health systems are forming their own drugmaker.
Infamous pharma exec Martin Shkreli’s social media posts have finally landed him in jail.
Martin Shkreli, who was convicted two weeks ago of federal criminal securities fraud, says he doesn’t think he will go to prison.
Allergan CEO Brent Saunders' pricing pledge has left a distinct mark on the industry, officially or not, Bernstein data show.
Martin Shkreli, who became notorious for jacking up the price of a drug by 5,000%, has been convicted in New York of federal securities fraud.
In the fraud trial of Martin Shkreli, former Retrophin executives painted a picture of biotech entrepreneur who was both brilliant and irresponsible.
As Martin Shkreli's trial opened, his lawyer tried a "misunderstood genius" narrative, while prosecutors called the defendant a liar and a con man.
New FDA Commissioner Scott Gottlieb has unveiled two new strategies aimed at tackling high drug costs right away.
